Boulder biotech space strong but grappling with tight capital, labor markets
BOULDER — Boulder’s biotech scene might feel a little less booming than it has been in recent years — due in part to a changing credit and capital environment in which money is no longer essentially free — but the industry’s fundamentals and foundation remain strong and ready to withstand the macroeconomic headwinds that could be on the horizon.
“The economic conditions around the country, we’re not immune to them here in Colorado,” Colorado Bioscience Association CEO Elyse Blazevich said Tuesday during BizWest’s CEO Roundtable on Life Sciences held at the University of Colorado Boulder’s BioFrontiers Institute.
Nevertheless, she said, new scientists…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
A trio of Boulder startup scene veterans is reviving the local Techstars accelerator program, which…
-
Medical-device firm Boulder iQ has nearly doubled its Boulder footprint with the purchase of a…
-
Powdr Corp., Eldora Mountain’s Utah-based parent company, plans to sell the Boulder County ski resort.
-
Edgewise Therapeutics Inc., a Boulder-based muscle disease biopharmaceutical company, increased its research and development spending…
